全文获取类型
收费全文 | 645篇 |
免费 | 34篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 26篇 |
妇产科学 | 6篇 |
基础医学 | 132篇 |
口腔科学 | 11篇 |
临床医学 | 61篇 |
内科学 | 39篇 |
皮肤病学 | 39篇 |
神经病学 | 64篇 |
特种医学 | 2篇 |
外科学 | 12篇 |
综合类 | 76篇 |
预防医学 | 31篇 |
眼科学 | 1篇 |
药学 | 162篇 |
中国医学 | 13篇 |
肿瘤学 | 15篇 |
出版年
2023年 | 11篇 |
2022年 | 12篇 |
2021年 | 14篇 |
2020年 | 9篇 |
2019年 | 12篇 |
2018年 | 9篇 |
2017年 | 16篇 |
2016年 | 17篇 |
2015年 | 16篇 |
2014年 | 18篇 |
2013年 | 59篇 |
2012年 | 19篇 |
2011年 | 22篇 |
2010年 | 16篇 |
2009年 | 13篇 |
2008年 | 20篇 |
2007年 | 25篇 |
2006年 | 16篇 |
2005年 | 23篇 |
2004年 | 25篇 |
2003年 | 23篇 |
2002年 | 18篇 |
2001年 | 26篇 |
2000年 | 13篇 |
1999年 | 18篇 |
1998年 | 15篇 |
1997年 | 18篇 |
1996年 | 7篇 |
1995年 | 13篇 |
1994年 | 8篇 |
1993年 | 11篇 |
1992年 | 5篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 5篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 13篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1974年 | 2篇 |
1968年 | 1篇 |
排序方式: 共有697条查询结果,搜索用时 0 毫秒
691.
692.
693.
《Vaccine》2023,41(19):3111-3118
BackgroundThe 10-valent pneumococcal conjugate vaccine (PCV10) was introduced for childhood vaccination in Brazil’s National Immunization Program in 2010. After nine years of PCV10 use, we investigated the carriage prevalence, capsular types, antimicrobial resistance and risk factors among children living in Niterói city, RJ, Brazil.MethodsBetween September and December 2019, we conducted a cross-sectional study and recruited children under 6 years of age. Antimicrobial susceptibility was evaluated by the disk-diffusion method and MICs to beta-lactams and macrolides were determined by E-test®. Capsular types were deduced by multiplex PCR. Logistic regression was used to predict risk factors for pneumococcal carriage.ResultsSeventy-five (17.4%) of the 430 children were pneumococcal carriers. The most frequent capsular types were 6C/D (14.7%), 11A/D (13.3%), and 23B (9.3%). PCV10 serotypes represented 5.3%. All isolates were susceptible to levofloxacin, linezolid, rifampicin, and vancomycin. Penicillin non-susceptible pneumococci (PNSP) made up 37.3%, with penicillin and ceftriaxone MICs ranging from 0.12 to 4.0 μg/ml and 0.064–4.0 μg/ml, respectively. Of the 19 (25.3%) erythromycin-resistant (ERY-R) isolates (macrolide MICs of 6 to >256 μg/ml), most had the cMLSB phenotype (84.2%) and carried the erm(B) gene (73.7%). We detected 17 (22.6%) multidrug-resistant (MDR) isolates, strongly associated with serotype 6C/D. Presence of any symptoms, chronic diseases, childcare center attendance, living with young siblings, slum residence, and unstable income were predictors of pneumococcal carriage.ConclusionsLong-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively. 相似文献
694.
695.
Sumiti Pareek MBBS Alpana Mohta MD Bhikham Chand Ghiya MD Yogesh Kumar MBBS 《Pediatric dermatology》2023,40(6):1101-1103
Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse reaction triggered in most cases by drugs. It is characterized by abrupt onset and rapid evolution of fields of sterile pustules on an erythematous background. The role of genetic predisposition in this reactive disorder is being explored. We report the simultaneous occurrence of AGEP in two siblings after being exposed to the same drug. 相似文献
696.
《Journal of infection and chemotherapy》2023,29(7):637-645
PurposeIn this study, we aimed to clarify the risk factors associated with unfavorable outcomes in adults with pneumococcal meningitis (PnM).MethodsSurveillance was conducted between 2006 and 2016. Adults with PnM (n = 268) were followed up for outcomes within 28 days after admission using the Glasgow Outcome Scale (GOS). After classifying the patients into the unfavorable (GOS1–4) and favorable (GOS5) outcome groups, i) the underlying diseases, ii) biomarkers at admission, and iii) serotype, genotype, and antimicrobial susceptibility for all isolates were compared between both groups.ResultsOverall, 58.6% of patients with PnM survived,15.3% died, and 26.1% had sequelae. The number of living days in the GOS1 group was highly heterogeneous. Motor dysfunction, disturbance of consciousness, and hearing loss were the commonest sequelae. Of the underlying diseases identified in 68.9% of the PnM patients, liver and kidney diseases were significantly associated with unfavorable outcomes. Of the biomarkers, creatinine and blood urea nitrogen, followed by platelet and C-reactive protein had the most significant associations with unfavorable outcomes. There was a significant difference in the high protein concentrations in the cerebrospinal fluid between the groups. Serotypes 23F, 6C, 4, 23A, 22F, 10A, and 12F were associated with unfavorable outcomes. These serotypes were not penicillin-resistant isolates possessing three abnormal pbp genes (pbp1a, 2x, and 2b), except for 23F. The expected coverage rate of the pneumococcal conjugate vaccine (PCV) was 50.7% for PCV15 and 72.4% for PCV20.ConclusionsIn the introduction of PCV for adults, the risk factors for underlying diseases should be prioritized over age, and serotypes with unfavorable outcomes should be considered. 相似文献
697.
Sarah Al-Obaydi Catherine A. Popadiuk Taha Al-Shaikhly 《Internal medicine journal》2023,53(8):1481-1484
The negative consequences of having a penicillin allergy label are well established. Penicillin allergy de-labelling improves healthcare outcomes; however, less attention is paid to modifying risk factors leading to penicillin allergy development. In this propensity score-matched retrospective cohort study, we used a de-identified population-based database (TriNetX Research Network) and examined the 30-day risk of acquiring a penicillin allergy label in patients using proton pump inhibitors (PPIs). We demonstrated a higher risk of acquiring a penicillin allergy label among PPI users compared to controls. 相似文献